Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
17 December 2021
Closing Date:
28 January 2022
Location(s):
PL415 Miasto Poznań (PL Poland/POLSKA)
Description:
Purchase and delivery of medicines from drug programs

The object of the order is the purchase along with the delivery of medicines from drug programs. A detailed description of the item of the order is included in Volume III SWZ.

The medicinal products offered must be entered in the official list of Pharmaceutical Measures and Medical Materials authorised for the market in Poland.

Package No. 1

Drug in the drug program - TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER

Package No. 10

Drug in the drug program - TREATMENT OF PATIENTS WITH ADVANCED OVARIAN CANCER, FALLOPIAN CANCER OR PERITONEUM CANCER, MEDICALLY PATIENTS WITH ADVANCED CERVICAL CANCER

Package No. 11

Drug in the drug program - TREATMENT OF ADVANCED COLON CANCER

Package No. 12

Drug in the drug program - TREATMENT OF FUNGAL GRANULOMA OR SEZARY'S SYNDROME

Package No. 13

Drug in the drug program - TREATMENT OF SEVERE ALLERGIC ASTHMA DEPENDENT IGE (ICD-10 J 45.0) AND SEVERE EOSINOPHILIC ASTHMA

Package No. 14

The drug in the drug program - ACUTE LYMPHOBLASTIC LEUKEMIA

Package No. 15

Drug in the drug program - TREATMENT OF ARTERIAL PULMONARY HYPERTENSION (TNP)

Package No. 16

Drug in the drug program - TREATMENT OF CHRONIC MYELOID LEUKEMIA

Package No. 17

Drug in the drug program - TREATMENT OF RESISTANT AND RELAPSE FORMS OF CD30+ LYMPHOMAS, TREATMENT OF PATIENTS WITH PRIMARY SKIN LYMPHOMAS T-CELLULAR

Package No. 18

Drug in the drug program - PROGRAMMING NON-SMALL CELL LUNG CANCER (ICD-10 C 34)

Package No. 19

Drugs in the drug program - TREATMENT OF KIDNEY CANCER

Package No. 2

Drugs in the drug program - TREATMENT OF BREAST CANCER

Package No. 20

Drug in the drug program - TREATMENT OF RESISTANT OR RELAPSE PLASMOCYTIC MYELOMA

Package No. 21

Drug in the drug program - TREATMENT OF NON-SMALL CELL LUNG CANCER

Package No. 22

Drug in the drug program - TREATMENT OF ADVANCED COLON CANCER

Package No. 23

Drug in the drug program - TREATMENT OF NON-SMALL CELL LUNG CANCER

Package No. 24

Drug in the drug program - TREATMENT OF RESISTANT OR RELAPSE PLASMOCYTIC MYELOMA

Package No. 25

Drug in the drug program TREATMENT OF CHRONIC MYELOID LEUKEMIA, TREATMENT OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Package No. 26

Drugs in the drug program - DRUG PROGRAM TREATMENT OF NON-SMALL CELL LUNG CANCER

Package No. 27

The drug in the drug program - TREATMENT OF NIGHT PAROXYSMAL HEMOGLOBINURIA (PNH)

Package No. 28

Drug in the drug program - TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER

Package No. 29

Drugs in the drug program - TREATMENT OF ADULTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA

Package No. 3

Drugs in the drug program TREATMENT OF NON-SMALL CELL LUNG CANCER WITH APHATINIB

Package No. 30

Drugs in the drug program - TREATMENT OF ARTERIAL PULMONARY HYPERTENSION

Package No. 31

Drugs in the drug program - TREATMENT OF NON-SMALL CELL LUNG CANCER

Package No. 32

Drug in the drug program - TREATMENT OF FAMILY HYPERCHOLESTEROLEMIA

Package No. 33

Drug in the drug program - IBRUTINIB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

Package No. 34

Drug in the drug program - TREATMENT OF ARTERIAL PULMONARY HYPERTENSION (TNP)

Package No. 35

Drug in the drug program - TREATMENT OF TUMORS OF THE DIGESTIVE TRACT (GIST)

Package No. 36

Drug in the drug program - TREATMENT OF PRIMARY IMMUNODEFICIENCIES (PNO) IN ADULTS

Package No. 37

Drugs in the drug program - TREATMENT OF PRIMARY IMMUNODEFICIENCIES (PNO) IN ADULTS

Package No. 38

Drug in the drug program - TREATMENT OF PRIMARY IMMUNODEFICIENCIES (PNO) IN ADULTS

Package No. 39

Drugs in the drug program - TREATMENT OF PRIMARY IMMUNODEFICIENCIES (PNO) IN ADULTS

Package No. 4

The drug in the program TREATMENT OF NEOASCULAR (EXUDATIVE) FORM OF AGE-RELATED MACULAR DEGENERATION (AMD)

Package No. 40

Drugs in the drug program - TREATMENT OF RESISTANT OR RELAPSE PLASMOCYTIC MYELOMA

Package No. 41

Drug in the drug program - TREATMENT OF BREAST CANCER

Package No. 42

Drugs in the drug program - LENALIDOMIDE FOR THE TREATMENT OF RESISTANT OR RELAPSE MULTIPLE MYELOMA

Package No. 43

Drug in the drug program - TREATMENT OF ARTERIAL PULMONARY HYPERTENSION (TNP)

Package No. 44

Drug in the drug program - TREATMENT OF SEVERE ALLERGIC ASTHMA DEPENDENT IGE (ICD-10 J 45.0) AND SEVERE EOSINOPHILIC ASTHMA

Package No. 45

Drug in the drug program - TREATMENT OF PATIENTS WITH ACUTE MYELOID LEUKEMIA

Package No. 46

Drug in the drug program - TREATMENT OF CHRONIC MYELOID LEUKEMIA

Package No. 47

Drug in the drug program - TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS

Package No. 48

Drug in the drug program - TREATMENT OF NON-SMALL CELL LUNG CANCER USING AFATINIB AND NINTEDANIB

Package No. 49

Drugs in the drug program - TREATMENT OF NON-SMALL CELL LUNG CANCER TREATMENT OF RENAL CANCER TREATMENT OF RESISTANT AND RECURRING FORM OF CLASSICAL HODGKIN LYMPHOMA WITH NIVOLUMAB

Package number 5

Drugs in the drug program- TREATMENT OF COLON CANCER

Package No. 50

Drug in the drug program -TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA OBINUTUZUMABEM

Package No. 51

Drugs in the drug program - OLAPARINE MAINTENANCE TREATMENT OF PATIENTS WITH RELAPSE PLATINOPULENT ADVANCED OVARIAN CANCER, FALLOPIAN CANCER OR PRIMARY PERITONEUM CANCER

Package No. 52

Drugs in the drug program - TREATMENT OF SEVERE ALLERGIC ASTHMA AND OMALIZUMAB DEPENDENT, APPLIES TO A DOSE OF 150 MG - TREATMENT OF CHRONIC SPONTANEOUS URTICARIA

Package No. 53

Drug in the drug program - TREATMENT OF NON-SMALL CELL LUNG CANCER

Package No. 54

Drug in the drug program - TREATMENT OF PATIENTS WITH METASTATIC PANCREATIC ADENOCARCINOMA

Package No. 55

Drug in the drug program - TREATMENT OF BREAST CANCER

Package No. 56

Drug in the drug program - TREATMENT OF ADVANCED COLON CANCER

Package No. 57

Drugs in the drug program - TREATMENT OF KIDNEY CANCER

Package No. 58

Drug in the drug program - TREATMENT OF NON-SMALL CELL LUNG CANCER

Package No. 59

Drug in the drug program - TREATMENT OF BREAST CANCER

Package number 6

Drug in the drug program - TREATMENT OF NON-SMALL CELL LUNG CANCER

Package No. 60

Drug in the drug program -TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS

Package No. 61

Drug in the drug program -PIXANTRON FOR THE TREATMENT OF MALIGNANT LYMPHOMAS

Package No. 62

Drugs in the drug program - TREATMENT OF RESISTANT OR RELAPSE MULTIPLE MYELOMA

Package No. 63

Drugs in the drug program TREATMENT OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA, TREATMENT OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA.

Package No. 64

TREATMENT OF NEOVASCULAR (EXUDATIVE) FORM OF AGE-RELATED MACULAR DEGENERATION (AMD)

Package No. 65

Drug in the drug program - TREATMENT OF BREAST CANCER

Package No. 66

Drugs in the drug program - DRUG PROGRAM TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION, TREATMENT OF ARTERIAL PULMONARY HYPERTENSION

Package No. 67

Drug in the drug program - TREATMENT OF PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA

Package No. 68

Drugs in the drug program - L. PRIMARY MYELOPHYBROSIS AND SECONDARY MYELOPHYBROSIS IN THE COURSE OF GENEINE AND HYPERPLAUDITY

Package No. 69

Drug in the drug program - TREATMENT OF ARTERIAL PULMONARY HYPERTENSION (TNP)

Package No. 7

Drug in the drug program - TREATMENT OF FAMILY HYPERCHOLESTEROLEMIA

Package No. 70

Drugs in the drug program - TREATMENT OF ARTERIAL PULMONARY HYPERTENSION

Package No. 71

Drugs in the drug program - TREATMENT OF KIDNEY CANCER, TREATMENT OF TUMORS OF THE DIGESTIVE TRACT (GIST)

Package No. 72

Drug in the drug program - TREATMENT OF KIDNEY CANCER, TREATMENT OF HEPATOCELLAR CANCER TREATMENT OF TUMORS OF THE DIGESTIVE TRACT (GIST)

Package No. 73

Drug in the drug program - TREATMENT OF KIDNEY CANCER

Package No. 74

Drug in the drug program - TREATMENT OF CHRONIC LUNG INFECTIONS IN CARE PROVIDERS WITH CYSTIC FIBROSIS

Package No. 75

Drug in the drug program - TREATMENT OF SOFT TISSUE SARCOMA

Package No. 76

Drug in the drug program - TREATMENT OF BREAST CANCER

Package No. 77

Drug in the drug program - TREATMENT OF ADVANCED STOMACH CANCER

Package No. 78

Drug in the drug program - TREATMENT OF BREAST CANCER

Package No. 79

Drugs in the drug program - TREATMENT OF BREAST CANCER

Package No. 8

Drug in the drug program - TREATMENT OF NON-SMALL CELL LUNG CANCER

Package No. 80

Drugs in the drug program -

TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (TNP)

Package No. 81

Drugs in the drug program - TREATMENT OF ADVANCED COLON CANCER

Possibility to swap doses within the package

Package No. 82

Drugs in the drug program - TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH VENETOCLAX OR VENETOCLAX IN COMBINATION WITH RITUXIMAB

Package No. 83

Drug in the drug program - TREATMENT OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Package No. 84

Drugs in the drug program - TREATMENT OF PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Package No. 85

Drugs in the drug program - Treatment of non-small cell or small cell lung cancer - a new program

Package No. 86

Drugs in the drug program - TREATMENT OF NON-SMALL CELL OR SMALL CELL LUNG CANCER

Package No. 9

Drug in the drug program - TREATMENT OF KIDNEY CANCER

Download full details as .pdf
The Buyer:
Szpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu
CPV Code(s):
33600000 - Pharmaceutical products